Status:
UNKNOWN
Antimicrobial Resistance in Cirrhotic Patients
Lead Sponsor:
Mansoura University
Collaborating Sponsors:
Tanta University
Conditions:
Cirrhosis
Eligibility:
All Genders
18+ years
Brief Summary
Cirrhotic patients are more vulnerable to bacterial infection, and infection is one of the most common causes of acute liver disease decompensation.
Detailed Description
Cirrhotic patients are more vulnerable to bacterial infection which is a common cause of acute liver disease decompensation. The aim of this study will characterize the antimicrobial resistance and di...
Eligibility Criteria
Inclusion
- 1\. Adults' older than 18 years with clinical evidence of liver disease
Exclusion
- Pregnancy
- Intensive care unite stay of more than 24 hours
- Malignancy
- Organ transplantation
- Acquired immune deficiency syndrome
Key Trial Info
Start Date :
June 7 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04915573
Start Date
June 7 2021
End Date
September 1 2021
Last Update
June 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tanta University Hospitals
Tanta, Egypt